JP2022549915A5 - - Google Patents
Info
- Publication number
- JP2022549915A5 JP2022549915A5 JP2022519458A JP2022519458A JP2022549915A5 JP 2022549915 A5 JP2022549915 A5 JP 2022549915A5 JP 2022519458 A JP2022519458 A JP 2022519458A JP 2022519458 A JP2022519458 A JP 2022519458A JP 2022549915 A5 JP2022549915 A5 JP 2022549915A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cells
- complex according
- pharmaceutical composition
- tlr agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025138126A JP2026004279A (ja) | 2019-09-30 | 2025-08-21 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962908305P | 2019-09-30 | 2019-09-30 | |
| US62/908,305 | 2019-09-30 | ||
| PCT/US2020/053258 WO2021067261A1 (en) | 2019-09-30 | 2020-09-29 | Knottin-immunostimulant conjugates and related compositions and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138126A Division JP2026004279A (ja) | 2019-09-30 | 2025-08-21 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022549915A JP2022549915A (ja) | 2022-11-29 |
| JP2022549915A5 true JP2022549915A5 (https=) | 2023-10-03 |
Family
ID=75337493
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519458A Pending JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
| JP2025138126A Pending JP2026004279A (ja) | 2019-09-30 | 2025-08-21 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138126A Pending JP2026004279A (ja) | 2019-09-30 | 2025-08-21 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220257785A1 (https=) |
| EP (1) | EP4037709A4 (https=) |
| JP (2) | JP2022549915A (https=) |
| KR (1) | KR20220071225A (https=) |
| CN (1) | CN114585382A (https=) |
| AU (1) | AU2020357806A1 (https=) |
| CA (1) | CA3156165A1 (https=) |
| WO (1) | WO2021067261A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109843327B (zh) | 2016-07-07 | 2022-05-13 | 小利兰·斯坦福大学托管委员会 | 抗体佐剂缀合物 |
| US12414997B2 (en) | 2018-04-13 | 2025-09-16 | Massachusetts Institute Of Technology | Brush prodrugs and uses thereof |
| WO2020190725A1 (en) | 2019-03-15 | 2020-09-24 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| JP2022533671A (ja) * | 2019-05-22 | 2022-07-25 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 薬物複合体およびその使用方法 |
| EP4045562A2 (en) * | 2019-10-16 | 2022-08-24 | Massachusetts Institute of Technology | Brush prodrugs and uses thereof |
| WO2025103490A1 (en) * | 2023-11-16 | 2025-05-22 | Beijing Changping Laboratory | N-oxide immune agonists activation by radiotherapy |
| WO2025193946A2 (en) * | 2024-03-14 | 2025-09-18 | Genentech, Inc. | Peptides binding lrrc15 and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10844106B2 (en) * | 2010-11-08 | 2020-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Fusion proteins comprising an engineered knottin peptide and uses thereof |
| US9587001B2 (en) * | 2012-10-19 | 2017-03-07 | The Board Of Trustees Of The Leland Stanford Junior University | Conjugated knottin mini-proteins containing non-natural amino acids |
| WO2014201245A1 (en) * | 2013-06-12 | 2014-12-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors |
| CA2957717C (en) * | 2014-08-12 | 2021-10-19 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2 and integrin-binding-fc-fusion protein |
| US10888603B2 (en) * | 2016-02-12 | 2021-01-12 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cancer cells expressing tumor-associated integrins |
| US10765625B2 (en) * | 2016-03-15 | 2020-09-08 | The Board Of Trustees Of The Leland Stanford Junior University | Knottin-drug conjugates and methods of using the same |
| MX2019012295A (es) * | 2017-04-14 | 2020-02-07 | Tollnine Inc | Polinucleotidos inmunomoduladores, conjugados de anticuerpos de los mismos y metodos para su uso. |
| JP2022533671A (ja) * | 2019-05-22 | 2022-07-25 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 薬物複合体およびその使用方法 |
| WO2022026906A2 (en) * | 2020-07-30 | 2022-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Lysosomal targeting molecules comprising knottin peptides and related compositions and methods |
-
2020
- 2020-09-29 AU AU2020357806A patent/AU2020357806A1/en active Pending
- 2020-09-29 CA CA3156165A patent/CA3156165A1/en active Pending
- 2020-09-29 EP EP20870659.8A patent/EP4037709A4/en active Pending
- 2020-09-29 KR KR1020227013406A patent/KR20220071225A/ko active Pending
- 2020-09-29 WO PCT/US2020/053258 patent/WO2021067261A1/en not_active Ceased
- 2020-09-29 JP JP2022519458A patent/JP2022549915A/ja active Pending
- 2020-09-29 US US17/762,694 patent/US20220257785A1/en active Pending
- 2020-09-29 CN CN202080072773.4A patent/CN114585382A/zh active Pending
-
2025
- 2025-08-21 JP JP2025138126A patent/JP2026004279A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022549915A5 (https=) | ||
| US20240173390A1 (en) | Peptide vaccine formulations and use thereof for inducing an immune response | |
| US20200392498A1 (en) | Polynucleotide constructs having bioreversible and non-bioreversible groups | |
| KR102634762B1 (ko) | 알파-v 베타-6 인테그린 리간드 및 그의 용도 | |
| US12370258B2 (en) | PD-1 and CTLA-4 dual inhibitor peptides | |
| US20160257961A1 (en) | Polynucleotide constructs having disulfide groups | |
| US20040014652A1 (en) | Tumor activated prodrug compounds and methods of making and using the same | |
| US20110087004A1 (en) | Enhanced oral transcompartmental delivery of therapeutic or diagnostic agents | |
| CN110650750A (zh) | 基于肽的疫苗、其制造方法及其用于诱导免疫应答的用途 | |
| WO2001091798A2 (en) | Tumor activated prodrug compounds | |
| EP2155177A2 (en) | Modification of biological targeting groups for the treatment of cancer | |
| AU2019272844B2 (en) | Improved methods of manufacturing peptide-based vaccines | |
| JP2024016040A (ja) | 去勢抵抗性前立腺癌 | |
| CN104587484A (zh) | 用于抗癌剂递送的聚合物系统 | |
| CN111093718A (zh) | 治疗性纳米缀合物及其用途 | |
| JP2022550901A (ja) | 核酸治療薬のための腫瘍標的化ポリペプチドナノ粒子送達システム | |
| CN116829178A (zh) | 小分子药物缀合物和表达car的细胞毒性淋巴细胞的组合及使用其治疗癌症的方法 | |
| CN109069577B (zh) | Hiv进入的d-肽抑制剂以及使用方法 | |
| JP2024500360A (ja) | 関連づけられた抗原および関連づけられたアジュバントを有する２つのポリマーソーム集団を投与することによる、Ｔｈ１／Ｔｈ２免疫応答の調整方法 | |
| CN120424167A (zh) | 双功能化合物及其在蛋白质靶向降解中的应用 | |
| CA2408103A1 (en) | Tumor activated prodrug compounds and methods of making and using the same | |
| KR102633963B1 (ko) | 생물학적으로 절단가능한 테트라펩티드 연결제 | |
| CN115515965A (zh) | 新型免疫刺激剂及其在免疫治疗中的用途 | |
| Vasievich et al. | Chemical Vectors for Delivery of Nucleic Acid‐Based Drugs | |
| Chen | Macrophage targeting using nanotechnology for HIV therapy |